erlotinib hydrochloride has been researched along with quercetin in 3 studies
Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (quercetin) | Trials (quercetin) | Recent Studies (post-2010) (quercetin) |
---|---|---|---|---|---|
4,353 | 786 | 3,033 | 12,403 | 239 | 7,510 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alavala, S; Andugulapati, SB; Bathini, NB; Chella, N; Ganthala, PD; Sistla, R | 1 |
Alanazi, MM; Alsaif, NA; Alsalami, OM; Bakheit, AH; Khan, AA; Wani, TA; Zargar, S | 1 |
Chan, CY; Chang, CM; Chen, YH; Hong, SC; Huang, CY; Liao, PC | 1 |
3 other study(ies) available for erlotinib hydrochloride and quercetin
Article | Year |
---|---|
Co-encapsulated nanoparticles of Erlotinib and Quercetin for targeting lung cancer through nuclear EGFR and PI3K/AKT inhibition.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Humans; Liposomes; Lung Neoplasms; Nanoparticles; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quality of Life; Quercetin | 2022 |
Interaction Characterization of a Tyrosine Kinase Inhibitor Erlotinib with a Model Transport Protein in the Presence of Quercetin: A Drug-Protein and Drug-Drug Interaction Investigation Using Multi-Spectroscopic and Computational Approaches.
Topics: Antioxidants; Carrier Proteins; Drug Interactions; Erlotinib Hydrochloride; Models, Molecular; Molecular Conformation; Protein Binding; Protein Kinase Inhibitors; Quercetin; Spectrum Analysis; Structure-Activity Relationship | 2022 |
Oral Squamous Cell Carcinoma Cells with Acquired Resistance to Erlotinib Are Sensitive to Anti-Cancer Effect of Quercetin via Pyruvate Kinase M2 (PKM2).
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Glucose; Head and Neck Neoplasms; Humans; Lung Neoplasms; Mice; Mouth Neoplasms; Pyruvate Kinase; Quercetin; Squamous Cell Carcinoma of Head and Neck | 2023 |